The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes?
Craig
Jonathan C
JC
School of Public Health, University of Sydney, Sydney, Australia. 2 Department of Nephrology, Children's Hospital at Westmead, Sydney, Australia. jonc@health.usyd.edu.au
Webster
Angela C
AC
McDonald
Stephen P
SP
D001379:Azathioprine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine